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ABBREVIATIONS 
ACS acute coronary syndrome 
CAD coronary artery disease 
CI confidence interval 
CTCA computed tomography coronary angiography 
ED Emergency Department 
ETT exercise treadmill test 
HR hazard ratio 
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Introduction 
Presentation to the hospital emergency department (ED) with acute chest pain is one of the 
most frequent occurrences, accounting for around a quarter of all hospital admissions. 1 Most 
commonly, management is directed towards the exclusion of acute coronary syndromes, 
using the presence (or absence) of cardiac risk factors, electrocardiographic changes and an 
appropriate rise or fall in biomarkers. 2 In patients where initial investigation excludes acute 
coronary syndrome (ACS), with a non-diagnostic ECG and negative cardiac biomarkers, 
current practice is to offer functional stress testing to elucidate the presence of significant 
underlying ischemia and provide prognostic information. Despite the improved performance 
and cost-effectiveness of non-invasive imaging techniques, in the United Kingdom stress 
testing is most commonly performed using the exercise treadmill (ETT), which provides 
important prognostic information. 3-6 Despite the widespread availability and use of the ETT, 
there are a significant proportion of patients who may not be able to undergo this test, for 
example those with poor exercise tolerance, poor mobility, or resting ECG abnormalities such 
as left bundle branch block. An inconclusive ETT, or worse, a non-performed one may lead to 
a dilemma in the subsequent management of the patient, potentially leading to unnecessary 
invasive coronary angiography. 
 
CT coronary angiography (CTCA) has recently been evaluated as a diagnostic test in patients 
presenting to the ED with acute chest pain, with encouraging results. 7-9 CTCA has also been 
shown to be more discriminatory for the diagnosis of ACS than ETT. 10 CTCA has shown 
prognostic value in this group of patients also for prediction of ACS during the initial 
admission. 11 Additionally, calcium scoring can also be performed prior to CTCA, which has 
shown mixed results for prediction of adverse events. 12, 13  
 
To the best of our knowledge, no study has yet evaluated the prognostic utility of CTCA and 
calcium scoring beyond the index admission in a cohort of patients unable to undergo a 
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functional test such as ETT. In this study, we wished to evaluate the prognostic performance 
of CTCA in this cohort of patients. 
 
Methods 
Patient Selection 
We prospectively evaluated 246 consecutive patients admitted to our ED with acute chest 
pain between 2008 and 2012. All patients had non-diagnostic ECGs (non-specific T wave and 
ST abnormalities) and negative troponin (cardiac troponin I, normal value <0.04 µg/L), thus 
excluding the diagnosis of ACS. All patients had intermediate pre-test probability of CAD 
(15-85%) as defined by the current ESC guidelines.14 All patients were either unable to 
undergo ETT (the usual standard of care in our unit) or had inconclusive tests and were thus 
referred for CTCA. ETT was performed using the full Bruce protocol.15 Inconclusive tests 
were defined as negative tests at low workload (below 3 Metabolic Equivalent) or with 
inadequate rise in heart rate (below 80% of max heart rate predicted by age), a positive ECG 
with resting ECG abnormalities precluding definitive diagnosis of ischaemia, 
symptomatically positive tests (angina or dyspnoea) with no ECG changes or ischaemic ECG 
changes with rapid resolution (<60s).16 We excluded all patients with contrast allergy, 
impaired renal function (estimated glomerular filtration rate <30ml/min), atrial fibrillation 
and resting heart rate >70 beats per minute (following adequate rate-limiting medication). 
Patients with moderately impaired renal function (estimated glomerular filtration rate 30-
60ml/min) were hydrated with intravenous fluids before and after CT scanning. . 
Additionally, nephrotoxic medications such as metformin were withheld for 48 hours either 
side of the CT contrast administration. These patients were also asked to attend their family 
practitioner in order to have their renal function checked 1 week after CT. The study was 
approved by our local ethics committee. 
 
Cardiac CT Examination 
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All patients were scanned using a 64-slice dual-source CT scanner (Discovery 750 HD, 
General Electric, Fairfield, CT, USA). All patients received sublingual GTN and oral ± 
intravenous beta-blocker to reduce heart rate to a target of less than 60 bpm. Patients unable 
to take beta-blockers were given verapamil for 3 days prior to the day of the CTCA as an 
alternative. 
 
For coronary calcium scoring an unenhanced CT was performed with the scan field to cover 
from the carina to the apex of the heart. CTCA was performed using ECG gating, with 
prospective acquisition if heart rate was less than 60 bpm and retrospective if greater than 70 
bpm. 80-120 ml (according to BMI) of iodinated contrast (Ultravist, Bayer, Germany) was 
injected into an intravenous cannula at a rate of 5ml/min followed by a bolus of saline. 
Scanning parameters were as follows: scan parameters: 100–140 kV tube voltage, 370–412 
mAs dependent on patient body habitus. Obesity was defined as body mass index >30 kg/m2.  
 
Cardiac CT Analysis 
Post-processing was performed offline on a dedicated workstation. All studies were evaluated 
by 2 physicians. Images were examined in the axial projection, with curved multiplanar 
reconstruction and using maximal intensity projection if needed. The coronary arteries were 
divided into 17 segments as per the AHA/SCCT model.17 Segments with poor image quality 
were excluded, as were any with coronary artery diameter <1.5mm. 
 
Calcium scoring was performed using the Agatston evaluation. Areas of calcium were 
measured using manual planimetry on axial images and the total calcium score was calculated 
automatically by the computer (Smartscore v 4.0, GE, Fairfield, USA). All 4 main epicardial 
coronary arteries (including left main) were fully evaluated. 
 
CT coronary angiography images were analysed offline using quantitative analysis on 
dedicated workstations (CardiQ Express v 2.0, GE, Fairfield, USA). The presence of 
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obstructive coronary stenosis was defined as the presence of an obstructive plaque ≥70% of 
the diameter of the reference vessel in two planes (≥50% in the left main coronary artery). 
Any stenosis of <70% (<50% in the left main) was classified as non-obstructive. 
 
Follow-up 
Patients were followed up for a combined primary outcome of death, non-fatal myocardial 
infarction and late revascularisation (>6 months from index admission) up to June 2014. 
Patients were followed up by clinic visits where appropriate and computerised record linkage. 
In case of inability to obtain follow-up data using these methods, the patient’s family 
practitioner was contacted. 
 
Statistical Analysis 
All statistical analysis was carried out using SPSS (version 22.0, IBM, Armonk, NY). All 
normally distributed continuous variables are reported as mean ± SD, while non-normally 
distributed variables are reported as median with interquartile range in brackets and all 
categorical data are presented as number and percentage. Comparison between continuous 
variables was carried out using a two-tailed t-test, while categorical variables were compared 
using the chi-square test. Outcome analysis was conducted using Cox proportional hazards, 
and time-to-event curves were drawn using the Kaplan-Meier method. All variables were 
evaluated using univariate Cox regression analysis to ascertain their prognostic power for 
prediction of the primary outcome. Hazard ratio and chi-square were obtained. All significant 
clinical univariable predictors (p<0.05) were then entered into a multivariable Cox model to 
identify significant multivariable clinical predictors.  
 
RESULTS 
Baseline Characteristics 
Of the 246 patients initially evaluated, 232 had satisfactory image quality to allow coronary 
artery analysis. Of the 14 patients excluded, 1 had inadequate coronary artery contrast 
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opacification due to inadequate contrast delivery through the intravenous cannula, 4 had 
arrhythmias during prospectively-gated scanning leading to unanalyzable segments, 3 had 
motion artefacts and 6 were unanalyzable due to the presence of heavy calcification. 
 
The majority of patients (59.5%) were referred for CTCA as they were unable to exercise for 
a sufficient time to reach a diagnostic heart rate. The average age of the cohort was 54.1 
years, while the majority of patients were female. Mean heart rate was 57 ± 4 beats/minute, 
mean radiation dose was 5.5 ± 0.6 mSv. Mean intravenous metoprolol dose given was 17 ± 
12 mg. 85% of the studies were performed prospectively while 15% were retrospective. Mean 
BMI was 27 ± 3 kg/m2. Mean time from initial presentation to CTCA was 13 ± 6 days. 
Reasons for referral for CTCA are shown in table 1 while baseline characteristics of the 
cohort are summarized in table 2.  
 
CTCA results are shown in table 3. The post-test prevalence of CAD was fairly low. The 
majority of patients had either no CAD or non-obstructive CAD, while 24 patients (10.3%) 
had obstructive CAD. 27 patients (11.6%) had left main stem or triple vessel CAD, while the 
median number of segments with any CAD was 1 (interquartile range 0-3). An example of 
CTCA findings is shown in figure 1. 
 
Predictors of the Primary Outcome 
Follow-up was available for all patients. Patients were followed up for a mean duration of 2.5 
± 0.9 years. The combined primary outcome occurred in 26 patients (11.2%). There were 2 
deaths, 4 myocardial infarctions, 14 readmissions with unstable angina and 6 percutaneous 
coronary revascularisations. The only significant univariable baseline clinical predictor of the 
primary outcome was being of male sex (HR 2.38; 95% CI 1.08-5.24, p=0.032). 
 
Both coronary artery calcium scoring and CT coronary angiographic features were significant 
univariable predictors of the primary outcome (Table 4). For every 100 Agatston unit increase 
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in calcium score there was a significant increase in the risk of adverse outcome (HR 1.16; 
95% CI 1.02-1.31, p=0.023). A high-risk calcium score (>400) was also associated with 
adverse outcome in univariable analysis (HR 3.08; 95% CI 1.16-8.17, p=0.024). The absence 
of coronary artery calcium was not significantly associated with a reduction in adverse events 
(HR 0.83; 95% CI 0.38-1.79, p=0.63). The presence of both non-obstructive (HR 4.52; 95% 
CI 1.30-15.73, p=0.018) and obstructive coronary artery stenoses (17.00; 95% CI 4.60-62.85, 
p<0.001) were significant predictors of the primary outcome (figure 2). Additionally, 
although the presence of non-calcified (mixed) plaque was not a predictor of adverse 
outcome, the presence of more than 3 segments with non-calcified plaque did predict adverse 
events (HR 3.30; 95% CI 1.24-8.76, p=0.017). 
 
In multivariable analysis the presence of coronary artery stenosis was the only significant 
predictor of adverse outcome with a worse outcome being predicted by the severity of the 
stenosis (non-obstructive HR 4.17; 95% CI 1.19-14.60, p=0.026; obstructive HR 12.43; 95% 
CI 3.17-48.80, p<0.001) (table 5). 
 
After exclusion of revascularisations and admissions for angina (leaving only “hard 
outcomes” of death and MI), age, beta-blocker use and the presence of 3 or more segments 
with non-calcified plaque remained significant predictors of death/MI in both univariable and 
multivariable analysis (table 6). 
 
Non-Coronary Diagnoses 
In total, 31 patients also had non-coronary diagnoses incidentally made during CT scanning, 
outlined in table 7. Several of these CT diagnoses lead to a change in management, including 
one early detection of a bronchial malignancy amenable to treatment, 4 diagnoses of 
pneumonia with radiological consolidation, one diagnosis of pulmonary fibrosis, one left 
atrial appendage thrombus requiring anticoagulation and one pericardial effusion. 
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DISCUSSION 
In this study we have added to the evidence that suggests that both CT calcium scoring and 
CT coronary angiography can be used in the early assessment of patients attending the 
emergency department with acute chest pain and negative troponins. Additionally, we have 
shown that the presence of both obstructive and non-obstructive coronary artery stenoses 
identified using CT coronary angiography are strong independent predictors of adverse 
outcome within this cohort of patients, and could be used when other methods such as 
exercise tolerance testing are not feasible or yield inconclusive results. Finally, CTCA may 
also provide an alternative diagnosis in this group and lead to changes in management beyond 
treatment of coronary artery disease. 
 
In the majority of patients presenting to hospital with acute chest pain, initial investigation is 
directed towards the exclusion of acute coronary syndromes (ACS). This involves a 
combination of clinical features, the resting electrocardiogram, and cardiac biomarkers. With 
the advent of high-sensitivity troponin, ACS can potentially be excluded within 6 hours of 
presentation to hospital. It is usual however, once ACS is excluded, to further risk stratify 
patients who are pain-free prior to discharge from hospital. The absence of significant 
ischemia on a pre-discharge ETT portends an excellent long-term prognosis. 5, 6 Because of 
this, and its widespread availability, excellent safety profile and ease of use, the pre-discharge 
ETT remains the most common modality for risk stratification in this group of patients and is 
recommended in both the European and American guidelines. 2, 18 
 
Despite the plethora of evidence for the use of the ETT, there are a number of patients who 
are unable to achieve a diagnostic test, while many others may be unable to undergo the test 
at all, either due to immobility or resting ECG abnormalities that may preclude evaluation of 
the test such as left bundle branch block.19, 20 Given this, it would be useful to have an 
alternative risk-stratification strategy in this group of patients. 
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Coronary calcium scoring provides a marker of risk which correlates well with the extent of 
atherosclerosis. The absence of coronary artery calcium (Agatston score = 0) has predicts a 
very low long-term risk of adverse events, particularly in patients with stable angina. 21 
Additionally, a high calcium score is known to be a strong predictor of mortality. 22  
 
Nevertheless, it is increasingly recognised that in many patients it is not calcified plaques that 
cause ACS, but so-called non-calcified plaques which might not be picked up by calcium 
scoring. 23 This may explain our finding that calcium scoring was not a significant 
multivariable predictor of adverse outcome. Our results extend the findings of those recently 
reported in a substudy of the ROMICAT II trial, in which the authors found that calcium 
scoring did not have any added value over and above CTCA in acute chest pain presentations. 
24 We have now extended this to provide prognostic information on calcium scoring, again 
finding that it is not as powerful a predictor of events as CTCA. 
 
CTCA has been shown to have excellent diagnostic and prognostic value in stable angina 
patients. The large, multi-centre SCOT-HEART trial showed the value of CTCA in 
assessment of patients with suspected stable angina referred to a rapid access chest pain 
clinic. 25 In this study we demonstrated that CTCA provided diagnostic and prognostic 
information. This potentially might allow the clinician to select patients who more targeted 
invasive investigation. Although several studies have shown the diagnostic accuracy of 
CTCA in acute chest pain, very few have specifically examined its prognostic benefit. 2-year 
outcome data from the original ROMICAT cohort showed that there were no adverse events 
in patients with no coronary artery disease. 11 This is very similar to the findings in our study, 
where we also found that the presence of CAD was the strongest predictor of adverse 
outcome. Our study also showed a trend towards the importance of plaque characterisation for 
the prediction of adverse events, with the presence of a significant burden of non-calcified 
plaque being associated with adverse outcome. This reflects recent data from a substudy of 
the ROMICAT-II trial which also showed the prognostic value of plaque characterisation.26 
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While the presence of non-calcified plaques in our study was not a significant multivariable 
predictor of adverse outcome, this may have been because of a relative lack of events in 
follow-up, which in itself is due to the low risk nature of the cohort. Interestingly however, 
the presence of more than 3 of non-calcified plaques was a strong predictor of “harder” 
outcomes (death and myocardial infarction). This may be a reflection of recent data which has 
shown that non-calcified plaques are more likely to be associated with death and acute 
coronary syndromes than calcified plaques regardless of stenosis severity.27, 28 
 
CTCA has been shown to be a valid alternative to ETT, and indeed may be more cost-
effective. 10 Our study suggests that CTCA could be used in patients in whom ETT is not 
possible, and indeed could potentially be utilized as a first-line alternative if available. An 
anatomical non-invasive imaging technique could potentially be a useful alternative to a 
functional imaging strategy as it is increasingly recognized that the presence coronary plaque 
seen on CT is predictive of adverse outcome, in particular acute coronary syndrome. 23, 29, 30 
Potentially, the identification of coronary artery disease using CTCA could lead to improved 
risk stratification and intensified preventative therapy. 
 
Our study has some limitations. Firstly, it was a single centre study with a relatively low 
event rate, although this was mitigated by a fairly substantial follow-up period. Our event-rate 
also compares well with that of the large ROMICAT prognostic data (11.2% vs. 9.5%).11 The 
addition of functional techniques such as CT fractional flow reserve or CT perfusion may also 
have provided further information. Nevertheless, as a relatively small observational study 
design this can only be viewed as a hypothesis-generating addition to the already published 
literature. This also limited our ability to look at the significance of CTCA in prediction of 
individual endpoints. Particularly, it limited our ability to perform a detailed multivariable 
analysis including only hard endpoints (death/myocardial infarction). In order to mirror 
typical “real-world” reporting practices and make our results more relevant to general 
cardiologists, we only used a simple measure of lesion severity (the presence of obstructive 
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CAD). There are however several other measures of CAD severity that we did not evaluate 
which may also be of prognostic importance in this group of patients such as the segment 
involvement score, Duke prognostic index and segment stenosis score. Further larger, 
randomised trials are warranted in order to investigate important parameters such as cost 
implications, optimal timing of scanning and potential benefits and complications of a CTCA-
guided management strategy in this group of patients. 
 
CONCLUSIONS 
Our study suggests that CT coronary angiography provides important prognostic information 
in patients attending hospital with troponin negative acute chest pain. CT coronary 
angiography could be used as an alternative strategy in patients unable to undergo exercise 
tolerance testing.   
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Table 1. Reasons for non-diagnostic ETT 
 
Reason Number (%) 
Poor mobility 73 (31.5) 
Fatigue (unable to achieve predicted heart rate) 65 (28.0) 
Borderline ST segment changes 30 (12.9) 
Symptoms but no ischemia at high workload 23 (9.9) 
Bundle-branch block on resting ECG 22 (9.5) 
Ischemia but no symptoms at high workload 19 (8.2) 
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Table 2. Baseline Characteristics of the Cohort. 
Characteristic All Patients 
(n=232) 
Suffered 
Primary 
Outcome 
(n=26) 
Did Not Suffer 
Primary 
Outcome 
(n=206) 
p value 
Age (years) 54.1 ± 10.9 56.9 ± 10.1 53.7 ± 11.0 0.14 
Male 98 (42.2) 16 (61.5) 82 (39.8) 0.035 
Diabetes Mellitus 17 (7.3) 1 (3.8) 16 (7.8) 0.70 
Hypercholesterolaemia 124 (53.4) 13 (50.0) 111 (53.9) 0.65 
Hypertension 96 (41.4) 15 (57.7) 81 (39.3) 0.08 
Smoker 31 (13.4) 3 (11.5) 28 (13.6) 0.75 
Previous MI/Angina 13 (5.6) 2 (7.7) 11 (5.3) 0.64 
Family history of 
CAD 
52 (22.4) 8 (30.8) 44 (21.4) 0.27 
Obesity 107 (46.1) 13 (50.0) 94 (45.6) 0.66 
Aspirin/clopidogrel  30 (12.9) 4 (15.3) 26 (12.6) 0.71 
Statin 114 (49.1) 12 (46.2) 103 (50.0) 0.69 
ACE Inhibitor 64 (27.6) 9 (34.6) 55 (26.7) 0.39 
Beta-blocker 49 (21.1) 7 (26.9) 42 (20.4) 0.43 
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Table 3. CT Coronary Angiography Results 
Characteristic All Patients 
(n=232) 
Suffered Primary 
Outcome (n=26) 
Did Not Suffer 
Primary Outcome 
(n=206) 
Calcium Score (Agatston 
units) 
0 (0-116.8) 0 (0-114.0) 0.5 (0-359.0) 
No CAD 99 (42.7) 3 (3.0) 96 (97.0) 
Non-obstructive CAD 109 (47.0) 14 (12.8)* 95 (87.2)* 
Obstructive CAD 24 (10.3) 9 (37.5)* 15 (62.5)* 
Left Main Stem/Triple 
Vessel Disease 
27 (11.6) 7 (26.9)+ 20 (9.7) 
Number of segments 
with any plaque 
1 (0-3) 1 (0-3) 1 (0-2) 
Number of segments 
with calcified plaque 
0 (0-2) 0 (0-1) 0 (0-2) 
Number of segments 
with non-calcified plaque 
0 (0-1) 0 (0-2) 0 (0-1) 
*p<0.05 compared to patients with no CAD; +p<0.05 compared to patients who did not suffer 
the primary outcome 
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Table 4. Univariable Predictors of the Primary Outcome. 
Characteristic Hazard Ratio (95% CI) p value 
Age 1.03 (0.99-1.06) 0.16 
Male 2.38 (1.08-5.24) 0.032 
Diabetes Mellitus 0.46 (0.06-3.40) 0.45 
Hypercholesterolaemia 0.86 (0.40-1.86) 0.71 
Hypertension 1.95 (0.90-4.25) 0.09 
Smoker 0.82 (0.25-2.75) 0.75 
Previous MI/Angina 1.43 (0.34-6.06) 0.63 
Family History of CAD 1.68 (0.73-3.88) 0.22 
Obesity 1.17 (0.54-2.53) 0.68 
Aspirin/clopidogrel  1.14 (0.39-3.32) 0.81 
Statin 0.88 (0.41-1.90) 0.74 
ACE Inhibitor 1.37 (0.61-3.06) 0.45 
Beta-blocker 1.38 (0.58-3.27) 0.48 
Calcium Score (per 100 Agatston 
units) 
1.16 (1.02-1.31) 0.023 
Calcium Score ≥400 3.08 (1.16-8.17) 0.024 
Calcium Score = 0 0.83 (0.38-1.79) 0.63 
Presence of any coronary artery 
stenosis 
6.34 (1.90-21.11) 0.003 
Presence of non-obstructive coronary 
artery stenosis  
4.52 (1.30-15.73) 0.018 
Presence of obstructive coronary 
artery stenosis  
17.00 (4.60-62.85) <0.001 
Presence of ≥1 non-calcified plaque 0.9 (0.43-2.10) 0.95 
Presence of ≥2 non-calcified plaques 1.67 (0.70-3.94) 0.25 
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Presence of ≥3 non-calcified plaques 3.30 (1.24-8.76) 0.017 
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Table 5. Multivariable Predictors of the Primary Outcome 
Characteristic Hazard Ratio (95% CI) p value 
Male 1.59 (0.71-3.60) 0.26 
Calcium Score (per 100 
Agatston units) 
1.07 (0.92-1.24) 0.37 
Presence of non-obstructive 
coronary artery stenosis  
4.08 (1.16-14.32) 0.028 
Presence of obstructive 
coronary artery stenosis  
12.00 (3.05-47.19) <0.001 
Presence of ≥3 non-calcified 
plaques 
2.09 (0.76-5.76) 0.15 
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Table 6. Predictors of Death or Myocardial Infarction 
Characteristic Univariable 
Hazard Ratio 
(95% CI) 
p 
value 
Multivariable 
Hazard Ratio (95% 
CI) 
p 
value 
Age 1.07 (1.00-1.06) 0.047 1.11 (1.00-1.23) 0.047 
Male 1.54 (0.31-7.67) 0.60   
Diabetes Mellitus 2.23 (0.26-19.13) 0.46   
Hypercholesterolaemia 0.88 (0.18-4.37) 0.88   
Hypertension 2.88 (0.53-15.73) 0.22   
Smoker 1.27 (0.15-10.85) 0.83   
Previous MI/Angina 1.43 (0.34-6.06) 0.63   
Family History of CAD 0.04 (0-174.45) 0.44   
Obesity 1.15 (0.23-5.71) 0.86   
Aspirin/clopidogrel  3.39 (0.40-29.02) 0.26   
Statin 0.52 (0.10-2.86) 0.45   
ACE Inhibitor 1.29 (0.24-7.02) 0.77   
Beta-blocker 7.36 (1.34-40.21) 0.021 14.45 (1.95-106.87) 0.009 
Calcium Score (per 100 
Agatston units) 
1.21 (0.95-1.53) 0.12   
Calcium Score ≥400 2.53 (0.30-21.70) 0.40   
Calcium Score = 0 0.42 (0.08-2.29) 0.32   
Presence of any 
coronary artery stenosis 
55.57 (0.08-
41068.83) 
0.23   
Presence of ≥3 non-
calcified plaques 
13.74 (2.77-68.20) 0.001 60.78 (6.68-552.71) <0.001 
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Table 7. Non-coronary Diagnoses Made During CT Scanning 
Diagnosis Number 
Lung nodule 15 
Pneumonia 4 
Liver cyst 4 
Pericarditis/pericardial thickening 2 
Pericardial effusion 1 
Bronchial Carcinoma 1 
Pulmonary fibrosis 1 
Splenic cyst 1 
Left atrial appendage thrombus 1 
Mediastinal lymphadenopathy 1 
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FIGURE LEGEND 
1. Examples of CT Coronary Angiography in the study. 
CTCA images in the right coronary artery (RCA) of 3 different patients. Patient A 
has no evidence of coronary artery disease (CAD) with a smooth RCA. B shows a 
patient with non-obstructive CAD in the distal RCA (arrows) while patient C has 
obstructive CAD in both the proximal and mid RCA (arrows). 
2. Kaplan-Meier Curves of the Primary Outcome. 
Time to event curves of the primary outcome using calcium scoring (A), CTCA (B) 
and the number of segments with non-calcified (mixed) plaques (C). 
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